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Abstract
Background: Progress on neonatal survival has been slow in most countries. While there is evidence on what works to
reduce newborn mortality, there is limited knowledge on how to deliver interventions effectively when health systems
are weak. Cluster randomized trials have shown strong reductions in neonatal mortality using community mobilisation
with women’s groups in rural Nepal and India. A similar trial in Bangladesh showed no impact. A main hypothesis is
that this negative finding is due to the much lower coverage of women’s groups in the intervention population in
Bangladesh compared to India and Nepal. For evidence-based policy making it is important to examine if women’s
group coverage is a main determinant of their impact. The study aims to test the effect on newborn and maternal
health outcomes of a participatory women’s group intervention with a high population coverage of women’s groups.
Methods: A cluster randomised trial of a participatory women’s group intervention will be conducted in 3 districts of
rural Bangladesh. As we aim to study a women’s group intervention with high population coverage, the same 9
intervention and 9 control unions will be used as in the 2005-2007 trial. These had been randomly allocated using
the districts as strata. To increase coverage, 648 new groups were formed in addition to the 162 existing groups that
were part of the previous trial. An open cohort of women who are permanent residents in the union in which their
delivery or death was identified, is enrolled. Women and their newborns are included after birth, or, if a woman dies
during pregnancy, after her death. Excluded are women who are temporary residents in the union in which their
birth or death was identified. The primary outcome is neonatal mortality in the last 24 months of the study. A low
cost surveillance system will be used to record all birth outcomes and deaths to women of reproductive age in the
study population. Data on home care practices and health care use are collected through interviews.
Trial registration: ISRCTN: ISRCTN01805825
Keywords: cluster randomised trial, neonatal mortality, community participation, Bangladesh, women’s groups
Background
The public health importance of addressing neonatal
mortality
Every year, 4 million babies die within the first 28 days
of life [1]. Another 3 million babies are stillborn, among
whom 1 million die during birth [2]. In addition,
between 343,000 and 500,000 women die during preg-
nancy, labour or 42 days post-partum [3,4]. Nearly all of
these deaths occur in low and middle income countries.
The faster reductions in post-neonatal and child mortal-
ity relative to neonatal mortality during the last decades
[1] have increased the importance of improving new-
born survival to achieve Millennium Development Goal
(MDG) 4 (to reduce under-five mortality by two-thirds
between 1990 and 2015) [5,6]. Currently, 42% of under-
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which 25-45% within the first 24 hours [1].
While neonatal, and in particular early neonatal, mor-
tality has been relatively resistant to change [1], effective
interventions are known for both home and health care
settings [7,8]. They include skilled antenatal and delivery
care as well as safe home care such as clean delivery
practices, breastfeeding and prevention of hypothermia
[8]. The scant progress in neonatal survival is contribu-
ted to by a lack of evidence on how to deliver effective
interventions in contexts where health systems are
weak. Every year 60 million women deliver without
skilled assistance [9], and maternity care is extremely
unequally distributed, with a minority of poor women
having access to such care in most low and middle
income countries [10]. Evidence is needed on how to
improve newborn survival in such contexts.
Newborn health in Bangladesh
While Bangladesh is on track to achieve MDG4 [11], its
burden of neonatal mortality is high. It is the 6
th coun-
try worldwide with the highest number of neonatal
deaths [7]. Around 57% of under-5 deaths in Bangladesh
occur in the first month of life [12], of which 74-83%
die in the first week [13-15]. About 37 out of 1,000
babies that are born alive die within the first 28 days of
life, with infections, low birth weight, and birth asphyxia
being the main causes of death [14]. While 60% of preg-
nant Bangladeshi women make at least one antenatal
care visit [12], only 18% of births (13% in rural areas)
are assisted by a medically trained provider. This is the
lowest coverage worldwide, apart from Ethiopia, Afgha-
nistan and Chad [16]. The vast majority of births (89%
in rural areas) is delivered at home, mostly with the
assistance of a traditional birth attendant [12].
Government policy on maternal, newborn and child
health of newly independent Bangladesh initially
focussed on the Expanded Programme on Immunisa-
tion, which includes immunisation against tetanus. This
led to a major reduction in neonatal tetanus during the
late 1970s and 1980s [14]. It was followed in 1998 by
the adoption of the Integrated Management of Child-
hood Illness (IMCI) strategy [17], which, in Bangladesh,
includes children from birth till 5 years of age. While
IMCI is now in place in most sub-districts, problems
remain with the provision of services. In 2009, a
National Neonatal Health Strategy and Technical Guide-
lines have been developed under the stewardship of the
Ministry of Health and Family Welfare, underscoring
the Government of Bangladesh’s commitment to achieve
MDG4 [18]. They include recommendations on normal
newborn care, neonatal sepsis, low birth weight babies,
birth asphyxia, and maternal health. Another national
programme geared to reduce maternal as well as
neonatal mortality in Bangladesh is the Community
Skilled Birth Attendants Programme, in which a cadre
of community health workers is being trained to assist
home deliveries. A pilot in 2003 has been evaluated as
successful and the programme is now being slowly
scaled-up [19], but coverage remains low. In addition,
several bilateral and non-governmental organisations are
active in Bangladesh to improve newborn health.
Community interventions and the need for further
research
Substantial reductions in neonatal mortality can be
achieved, even in contexts where health care systems are
very weak, as has been shown in cluster randomized
trials of community mobilisation with women’sg r o u p s
in rural Nepal and rural tribal areas in India [20,21].
These interventions were modelled on a before-and-
after study in remote rural Bolivia, which used a partici-
patory learning and action cycle with women’sg r o u p s
to improve home care practices and health care use
[22]. The women’s groups, under the guidance of a facil-
itator, went through a cycle of meetings, in which they
identified and prioritized maternal and newborn health
problems, and subsequently developed, implemented
and evaluated strategies to address these problems, with
the support of the entire community. The studies in
Nepal and India showed a 30% and 45% reduction in
neonatal mortality respectively. There are indications
that such participatory strategies for behaviour change
are more effective than one-to-one health education
[ 2 3 ] .T h i si sc o n s i s t e n tw i t hB a n d u r a ’s social learning
theory, which stresses the importance of social interac-
tion, and hence involving the wider community, for
behaviour change [24].
There are still questions about the factors that influ-
ence the impact of women’s group interventions on
newborn mortality. The intensity and coverage of com-
munity mobilisation might be two such factors. The
community mobilisation arm of the Prohjanmo trial in
Bangladesh, which was far less intensive than the
women’s group interventions in Nepal and India,
showed no impact on neonatal mortality [25]. A
women’s group trial running between 2005 and 2007 in
rural Bangladesh, of similar high intensity as in Nepal
and India also showed no impact on neonatal mortality,
or on most home care practices and health behaviours
[13]. A main hypothesis is that this was due to the
much lower coverage of women’s groups in the Bangla-
desh 2005-2007 trial (1 women’s group per 1414 popu-
lation) compared to Nepal (1:756) and India (1:468). For
evidence-based policy making, it is important to better
understand these factors. The potential of women’s
groups to reduce newborn mortality is high and the
costs are low [21,26]. Their scalability in the Bangladesh
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a variety of activities such as micro-credit, is high.
This study will examine whether coverage is an
important factor influencing the effect of women’s
groups on neonatal mortality. It will test the effect on
neonatal mortality of an intensive women’sg r o u pi n t e r -
vention with high population coverage.
Methods/Design
Objectives and research questions
Goal
To improve newborn and maternal health and survival
in Bangladesh.
Objective
To test the effect on newborn and maternal health out-
comes of a participatory women’s group intervention
with a high coverage of women’sg r o u p si nt h e
population.
Primary research question
What is the effect of a participatory women’sg r o u p
intervention with a high coverage of women’s groups on
the neonatal mortality rate?
Ancillary questions
What is the effect of a participatory women’sg r o u p
intervention with a high coverage of women’s groups on:
1. early and late neonatal mortality, stillbirth rate,
pregnancy-related mortality ratio, maternal mortality
ratio;
2. maternal and newborn home care practices;
3. maternal and newborn health service utilisation.
Trial design overview
The intervention will be evaluated using a cluster rando-
mized trial design. The rationale is that the intervention
is applied to the entire community, involving both regu-
lar women’s group meetings as well as direct involvement
of the wider community. Unions, the lowest administra-
tive level in Bangladesh, are randomized into intervention
or control. Because of the nature of the intervention, allo-
cation is not masked. Eighteen unions, 9 intervention and
9 control, with a population of around 28,400 each, are
included. The entire study population is around 512,000
people. We have set up a prospective surveillance system
in which all live births, stillbirths, neonatal deaths and
deaths to women of reproductive age in the study popu-
lation are recorded and combined with data on home
care practices and health care use collected through an
interview 6 weeks post-partum [27].
Setting
The study areas are located in three rural districts of
Bangladesh, representing the country’s different
geographical features [Figure 1]. Moulvibazar district in
the northeast is hilly, making travel difficult, and con-
tains socio-economically more deprived tea garden
estates with tea garden workers. Faridpur district, to the
south of Dhaka, is characterized by large rivers, regularly
causing floods and making some unions inaccessible.
The study areas in the northern district of Bogra are
quite scattered, and recruitment and retention of project
staff is comparatively difficult.
Data from our surveillance system show that over 80%
of the population in the study areas is Muslim, with
nearly all the remainder being Hindu. About half of the
women giving birth in the study areas have received no
formal education or only primary education. The vast
majority of women deliver at home, without professional
assistance. In 2007, neonatal mortality was around 35/
1,000 in both intervention and control unions. In Ban-
gladesh, primary care is provided at Union Health and
Family Welfare Centres and at Community Clinics. In-
and out-patient services, including emergency obstetric
care, are provided at sub-district (upazilla) health com-
plexes and hospitals, and tertiary care is provided at dis-
trict hospitals and medical college hospitals. In practice,
both availability and quality of health care, including
maternity care, are important problems in our study
areas, due to a lack of facilities and trained health care
providers, short supplies of medicines and low respon-
siveness of services.
The trial is implemented by the Perinatal Care Project
(PCP) with technical assistance from the University Col-
lege London (UCL) Centre for International Health and
Development. PCP was established in 2002 as a colla-
boration between the Diabetic Association of Bangla-
desh (BADAS), the UCL Centre for International Health
and Development (UK), and Women and Children First
(UK). In the same study areas, PCP also implemented
the 2005-2007 women’s group trial, of which the current
study is a follow-up.
Study population
In the intervention areas, the target group for the
women’s group meetings are permanent residents of
reproductive age, in particular pregnant and newly mar-
ried women. However, other women, such as older in-
laws and adolescent girls are also welcome. Community
health workers sometimes also participate. Men are
allowed, but rarely do attend. The wider community,
including both men and women, is involved through,
among others, community meetings.
The study population is an open cohort of women, liv-
ing in the study area, who are permanent residents of
the union in which their delivery or death was identi-
fied. Women and their newborn infants are included
after birth, or, if a woman dies during pregnancy, after
Houweling et al. Trials 2011, 12:208
http://www.trialsjournal.com/content/12/1/208
Page 3 of 11her death. A woman is considered a permanent resident
o fau n i o ni ft h eh o u s es h en o r m a l l yl i v e si ni si nt h a t
union. Excluded are women who are registered as tem-
porary residents in the union in which their delivery or
death was identified. These are predominantly women
who temporarily move to their parents’ house in a
different union to give birth, after which they return to
their husband’s house. On the basis of data from our
ongoing surveillance system, we expect 15% of births to
occur to women who temporarily move into the PCP
s t u d ya r e at og i v eb i r t h ,a n d6 %o fb i r t h st oo c c u rt o
women who temporarily move to a different union
Figure 1 Study areas.
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deaths occur during the first week of life, and given the
nature of the intervention, in which women’sg r o u p
membership is open to permanent residents and in
which entire communities are mobilised to take action
during pregnancy, delivery and the newborn period, we
expect to see mainly an effect among women who are
permanent residents in the union in which they give
birth.
Intervention
Community mobilisation through women’s groups
The intervention to be evaluated is a participatory learn-
ing and action cycle with women’s groups. Facilitators,
who are local women of reproductive age with at least a
high school degree, recruited, trained and paid by PCP,
convene monthly women’s group meetings. As we aim
to study the effect of a women’s group intervention with
high population coverage, 648 new groups were formed
by newly recruited facilitators and started to meet from
January 2009 onwards, in addition to the 162 women’s
groups that were already set up in the intervention areas
as part of the 2005-2007 trial [13]. These ‘old’ groups
have continued to meet on a monthly basis from late
2004 onwards [13]. The 648 new groups will go through
a cycle of monthly meetings on maternal and newborn
health (Cycle 1), while from April 2010 the 162 ‘old’
groups will proceed to a cycle of meetings on under-5
and women’s health (Cycle 2) and periodically review
maternal and newborn health issues. Membership of the
‘old’ groups has been relatively stable. The combined
810 women’s groups constitute a coverage of 1 group
per 300 population, compared to 1 per 1414 in the
2005-2007 trial.
Each facilitator is responsible for 18 groups. She
guides the groups through a four-phased community
action cycle [22], in which she activates and supports
the groups to identify and prioritize maternal and new-
born (cycle 1), or child and women’s (cycle 2), health
problems (phase 1), plan strategies to address these pro-
blems (phase 2), and implement (phase 3) and evaluate
(phase 4) these strategies (Figure 2). At the end of phase
2 and at the start of phase 4 community meetings will
be held to engage the wider community in the develop-
ment and implementation of the strategies. The facilita-
tor uses picture cards and a flip chart as means to
stimulate discussion. Facilitators received training in
participatory communication methods and in basic
maternal and newborn (Cycle 1) and child and women’s
health (Cycle 2) issues. Except for the paid facilitator
and tools, no resources are provided to the groups. The
groups meet on a monthly basis throughout the inter-
vention period. We expect occasional interruptions of
the meeting schedule, for example during the monsoon
and Ramadan. Within the 21/2 year period, we expect
all groups to have held at least 20 meetings.
The 2005-2007 intervention has been adapted to
increase participation of pregnant women in the
women’s groups. Pregnant women in the community
are now identified by facilitators, traditional birth atten-
dants (TBAs), community health workers and women’s
group members, and are encouraged to attend the
groups. Facilitators visit pregnant women and their
families to explain the benefits of attending the women’s
and they keep a record of the number of pregnant
women attending the groups.
Health systems strengthening
Both intervention and control clusters will receive health
system strengthening activities. The reason to include a
health systems strengthening component in our study is
twofold. First, there is the ethical imperative to ensure
that also the control areas benefit from the study. Sec-
ond, we expect some degree of a functioning local
health system to be necessary for the success of a
women’s group intervention [20]. The health systems
strengthening strategy contains four components: sensi-
tisation of community health committees (set up by the
Ministry of Health and Family Welfare) to maternal and
newborn health issues; basic training of traditional birth
attendants in essential newborn care; financial and orga-
nisational support of training of doctors; and provision
of weighing scales and sphygmomanometers to the 44
community clinics operating in the study area.
Randomisation
The same intervention and control unions were used as
for the 2005-2007 trial. The randomisation for that trial
was as follows: the three study districts, Bogra, Faridpur
and Moulvibazar, were purposefully sampled on the
basis of having active Diabetic Association of Bangladesh
(BADAS) offices (Figure 3). In each of these districts, 2
upazillas (sub-districts), and within each upazilla 3
unions were purposefully sampled on the basis of
recommendations from BADAS representatives, using
perceived limited access to perinatal health care and a
feasible travelling distance by motorbike from BADAS
district headquarters as the main criteria. The 18 unions
were randomly allocated to either intervention or con-
trol (9 intervention and 9 control), with each district
constituting one stratum, in the presence of four project
staff (including the project director and project man-
ager) and two people external to the study team (Dr.
Nazmun Nahar, Department of Paediatrics, Dhaka Med-
i c a lC o l l e g e ,D h a k a ,a n dD r .A z a dK h a n ,B A D A S ,
Dhaka). For each district, cluster names were written on
pieces of paper, which were folded and placed in a bot-
tle. The project manager then drew the papers from the
bottle. The first three cluster names drawn were
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three to control. The allocation sequence had been
decided upon by the project team before drawing the
papers [13].
Reducing contamination
We expect little contamination from the intervention to
the control areas. The intervention and control clusters
are mostly geographically far apart, though in the few
adjacent intervention and control unions, a small num-
ber of women from the control areas do participate in
the women’s group meetings. Mobility, in particular of
women of reproductive age, is socially restricted, and
opportunities for social mixing between unions are lim-
ited. However, a substantial proportion of women tem-
porarily move to their parents’ house for delivery. From
Figure 2 Community action cycle.
MOULAVIBAZAAR DISTRICT BOGRA DISTRICT FARIDPUR DISTRICT
Bhatra Bhatgram Digdair
Balua Thalta 
Majhgram
Jorgacha
Char 
Bishnapur
Bhashan-
char
Aliabadh Monsur 
Nagar
Madhabpur Rahimpur
Munshi 
Bazaar
Tengra Pachgaon Krioshna-
pur
North 
Channel
Char 
Madhabdia
WOMEN’S GROUP TRIAL
9 women’s group intervention clusters 
9 women’s groups control clusters
All 18 clusters receive health service strengtheninig
Intervention cluster
Control cluster
Figure 3 Randomisation.
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a r r i v i n gf r o mo u t s i d et h es t u d ya r e a .T h et e m p o r a r y
movement within the study area is expected to be
mostly within the same union, rather than between
unions. Our study population excludes women that are
temporary residents in the union in which their delivery
or death was identified.
Sample size
Sample size was determined following equations from
Hayes and Bennett and Hayes and Moulton [28,29],
using Microsoft Excel 2003. The trial, with two treat-
ment arms, includes 9 intervention and 9 control areas
with an average population of 28,400. The clusters are
unmatched. We used 2005-2008 data from our ongoing
surveillance system to come to conservative estimates of
the number of live births among permanent residents
per cluster per year (445), the baseline neonatal mortal-
ity rate (34/1,000), and the between-cluster coefficient of
variation[28] for neonatal mortality (k = 0.099), assum-
ing an equal k in intervention and control areas. We
assume a 6-month time lag in effect on the basis of
findings of similar trials [21]. The study will have
between 86% and 90% power to detect a 30% difference
in neonatal mortality between the intervention and con-
trol arm during the last 24 months of the study. Statisti-
cal power remains the same after the exclusion of tea
garden residents.
Impact evaluation
The primary outcome of our study is the neonatal mor-
tality rate (number of deaths in the first 28 complete
days after birth per 1,000 live births) in the last 24
months of the study. Secondary outcomes are early and
late neonatal mortality rate, stillbirth rate, perinatal
mortality rate, pregnancy-related mortality ratio, mater-
nal mortality ratio, and health care use and home care
practices during pregnancy, delivery and the neonatal
period.
Data collection and management
A low-cost prospective surveillance system will be used
to record all deaths during pregnancy up to 6 weeks
post-partum and all births and their outcomes (live
birth, stillbirth, neonatal death). This system has been in
place in the study areas since 2005, and will be main-
tained throughout the study period (Figure 4). Data are
Key Informer
Identifies all …
Stillbirths
Deaths  to women of reproductive age Births
Interviewer 
ascertains all…
Alive at 28 days
Live births
Maternal and 
pregnancy related 
deaths
Other deaths
Interviewer
ascertains all:
Neonatal deaths
Compute MR
Supervisor
Conducts verbal autopsies 
Alive at 28 days
Interviewer
Conducts interview with family member 
regarding mother’s background 
characteristics, ante-partum, intra-partum, 
post-partum periods, and the newborn
Interviewer
Conducts interview with mother regarding 
background characteristics, ante-partum, 
intra-partum, post-partum periods, and 
the newborn
eo ata deat s
Figure 4 Surveillance system.
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all TBAs, are responsible for identifying all women that
have given birth and all deaths to women of reproduc-
tive age. Each key identifier covers a geographical area
of around 200 households. TBAs conduct the majority
of deliveries in our study area, and are in a good posi-
tion to identify births, irrespective of whether they
attended them. They are mostly middle-aged women,
who are less restricted in movement than newly married
women. A full-time salaried monitor (37 monitors work
in the study area) meets with the key identifier twice
per month to collect the list of identifications. The
monitor visits the household to verify the births and
deaths, and, for deaths to women of reproductive age,
asks if the death occurred during pregnancy up to 6
weeks post partum. The monitor pays the key identifier
Tk100 (€1.08, December 2010) for each accurate identi-
fication and makes an appointment for the interview.
The monitor conducts the interview, which covers back-
ground characteristics, and the antenatal, delivery and
postpartum periods. In the event of a live birth, still-
birth, or neonatal death, the interview is done with the
mother at around 6 weeks post-partum. In the event of
a stillbirth or neonatal death, a verbal autopsy is also
conducted with the mother. In the case of a death of a
woman during pregnancy or up to 6 weeks post-partum,
the interview and a maternal verbal autopsy are con-
ducted with a close relative or friend. All eligible
women identified are asked if they can identify any
other recent deliveries, deaths to women of reproductive
age or newborn deaths. Around 20% of questions of 10-
20% of all interviews are cross-checked through a re-
interview by the monitoring coordinator. Hard copies of
the lists of identifications and of the interviews are sent
on a monthly basis to the surveillance manager at the
PCP head office in Dhaka. The identifications are
entered into an SPSS database dedicated to following-up
the birth outcomes. The interview data are entered into
a Microsoft Access database. The two datasets can be
linked using unique identification numbers. All hard
copy questionnaires are archived for future reference.
Similar surveillance systems are being used in Nepal,
India and Malawi [20,27,30,31].
Dealing with loss-to-follow-up
For up to 1 year after the birth identification, the moni-
toring team will seek to obtain information on birth
outcomes, pregnancy-related mortality, maternal mortal-
ity and health related behaviours, including for mothers
who have temporarily or permanently migrated after
birth. After one year, they will be considered lost to fol-
low-up. Interviews are arranged at a time that is conve-
nient for the respondent, and monitors are instructed to
only conduct an interview if the respondent feels at
ease. On the basis of our previous trial, we expect non-
response to be very low.
Interim analyses and stopping rules
A meeting of an independent Data Safety Monitoring
Board (DSMB) will be convened according to the
DAMOCLES charter [32], after 11/2 years of accumu-
lated surveillance data. The DSMB will be tasked to pro-
vide an independent, objective review of the study
implementation and accumulated interim data, and to
advise on any extension or modification of the trial. In
particular, it will review (i) process indicators including
women’s group coverage and adherence to the imple-
mentation plan, (ii) adequacy of the sample size, (iii)
comparability of treatment arms, (iv) data quality, and
(v) the proposed analysis plan. The intervention alloca-
tion will be masked to the board. There are no stopping
rules as we do not expect the intervention to have
adverse effects at either cluster or participant level.
Analysis plan
The trial will test the effect of a community mobilisation
intervention with a high coverage of women’s groups. Of
the 810 women’s groups, 162 are existing groups, which
have been meeting from late 2004 onwards, and 648 are
new groups, which held their first meeting in January
2009. The 648 new groups focus on pregnancy, delivery
and the newborn period (Cycle 1). The 162 old groups
focussed on the same until April 2010, after which they
started to discuss under-5 and women’s health (Cycle
2). The study does not intend to separate out the effects
of the old and the new groups, nor of Cycle 1 and Cycle
2. Therefore, any difference in primary and secondary
outcomes between intervention and control areas can be
due to: (i) increase in coverage of Cycle 1 from 1/1414
to 1/376 (i.e. from 162 to 648 groups), (ii) a ‘booster
dose’ of 162 women’s groups with a coverage of 1/1414,
( i i i )a ni n c r e a s ei nc o v e r a g eo fw o m e n ’sg r o u p si ng e n -
eral (Cycle 1 and 2) from 1/1414 to 1/300. Given that
the previous trial had no impact on primary and sec-
ondary outcomes and that the focus of Cycle 2 is on the
post-neonatal period, we expect any impact on primary
and secondary outcomes to be mainly due to increased
coverage of Cycle 1.
Analysis will be by intention to treat at the individual
and cluster level. Participants are assigned to the cluster
in which their birth is registered. The intention-to-treat
population only includes women that are permanent
residents in the union in which their delivery or death is
registered. Participants with missing data on the primary
outcome will be excluded from the analyses. The control
clusters include three tea garden areas with substantially
worse health and socio-economic outcomes compared
to the rest of the study area, compromising the compar-
ability of the treatment arms. Analyses will therefore be
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Furthermore, all analyses will be carried out without
and with adjustment for potential confounders. Esti-
mates of the intervention effect will be presented with
95% confidence intervals. All analyses will take the clus-
tered design of the study into account. We intend to
use STATA-10 to perform the analyses.
As we expect a 6 month time lag for the intervention
to take effect, we will use as the trial’s primary endpoint
the neonatal mortality rate in the last 24 months of the
trial.
Process evaluation
Detailed quantitative and qualitative process evaluation
information will be collected throughout the interven-
tion period, to help explain any differences in effect
between the old (2005-2007) and the current trial, and
formulate alternative hypotheses for the lack of impact
of the old trial in comparison with similar trials in India
and Nepal. Information will be collected on (1) interven-
tion process, including fidelity to the original interven-
tion protocol, (2) contextual factors that may influence
intervention impact, (3) exposure to and participation in
the women’s group intervention, in particular among
pregnant women, and (4) receipt of the intervention by
the target population.
Timetable
The intervention period is between 1 January 2009 and
30 June 2011 (30 months).
Ethical issues
Approvals
The trial has been approved by the University College
London Research Ethics Committee (ID Number: 1488/
001) and by the Ethical Review Committee of the Dia-
betic Association of Bangladesh. The trial has been
registered with ISRCTN01805825.
Community consultation
Community leaders were identified through a resource
mapping exercise, and approached to obtain permission
to form 648 new women’s groups in the existing PCP
study areas. Orientation meetings were held to explain
the aims of the women’s groups and to identify potential
women’s group members.
Consent
Participation in women’s groups and community meet-
ings is on a voluntary basis. The participants can choose
to leave at any time. Prior to all interviews, the purpose
of the data collection is explained and verbal consent
from the interviewee obtained. Interviewees are told that
they are free to decline the interview, and can refuse to
answer any question. Access to the identifiable
individual-level data is limited to surveillance and data
entry staff and analysts from the study team.
Treatment of illness in study areas
Field workers that encounter a sick child or mother are
advised to refer them to an appropriate health care
facility.
Benefits to control areas
We have equipoise on the intervention under test: the
effect of an intensive participatory women’s group inter-
vention with a high coverage of women’sg r o u p si s
unknown for the Bangladesh context. More generally, it
remains unknown if coverage is an important factor
determining the magnitude of effect of women’sg r o u p s
on neonatal mortality. Therefore it is important to test
the effect of this intervention using a randomized trial
design. It is ethically important that the control areas
also benefit from the study. They will do so in two
ways. First, they will benefit directly, through the health
systems strengthening activities that will be undertaken
in both study arms. Secondly, they will benefit indirectly,
through our advocacy activities at the local, national and
international level, and through our surveillance activ-
ities, that both are an integral part of our programme.
The advocacy activities seek to put maternal and new-
born health higher on the political agenda, using health
data collected from the study areas.
Scalability
The potential for scaling-up a low cost community
mobilisation intervention in Bangladesh is high. Scale-
up would be facilitated by the fact that PCP is a part of
BADAS, the largest health care provider in Bangladesh
after the government. BADAS has strong links with the
Ministry of Health and Family Welfare and the Ministry
of Social Welfare, which can influence the policy making
process. Furthermore, the many women’sg r o u p sa n d
community groups in Bangladesh set up by other orga-
nisations, provide a social context which may allow for
add-on of a maternal and newborn health component.
Role of funder
The funder has no role in the design of the study, the
data collection, analysis, interpretation or write-up of
the findings.
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